Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.

Author: Nauck, Michael A. MD; Meier, Juris J. MD; Cavender, Matthew A. MD, MPH; Abd El Aziz, Mirna MD; Drucker, Daniel J. MD

Page: 849-870

http://ift.tt/2vEHYap